Google Alert - Business

	Business Daily update ⋅ December 9, 2024
	NEWS
	City of Hope 'Double-Barreled' Drug Shows Early Promise for Blood Cancer City of Hope Patients with chronic lymphocytic leukemia demonstrated a favorable response to a novel bispecific antibody in a City of Hope clinical trial. "I'm a clinical trials junkie!" So says Brian Koffman, M.D., a 73-year-old retired family physician from ... Flag as irrelevant
	OncLive Combining BCL-2 and BTK inhibitors shows promise in CLL Dana-Farber Cancer Institute A novel, fixed-duration drug combination — consisting of a second-generation BTK inhibitor, called acalabrutinib, plus a BCL-2 inhibitor (venetoclax), with or without a third blood cancer drug — shows deep and durable responses in patients with chronic ... Flag as irrelevant
	Glam Adelaide Landmark research centre positions Australia for a safe and responsible AI future CSIRO The landmark collaboration will bring together experts from Australia's national science agency, CSIRO, and The University of Adelaide, in partnership with the South Australian Government. The Responsible AI Research (RAIR) ... Flag as irrelevant
See more results | Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback